HEALTH TECHNOLOGY

Internova Travel Group Partners with Forbes Travel Guide and Sharecare to Adopts Health Security Verification Platform

Internova Travel Group | November 03, 2020

Internova Travel Group Partners with Forbes Travel Guide and Sharecare to Adopts Health Security Verification Platform

In its proceeded with worldwide activity to guarantee customers can travel with certainty and remain in a protected climate, Internova Travel Group has chosen advanced wellbeing organization Sharecare and Forbes Travel Guide as wellbeing security check accomplices to approve the strategies and conventions at in excess of 50,000 inns booked through its frameworks. The dynamic arrangement will help the travel business adjust on a typical methodology, predictable conventions, and a set up arrangement of wellbeing security, state organization heads.

 

"This verification process will allow us to evaluate the quality of the vast myriad of health policies and solutions that exist at hotels throughout the world, as well as highlight those who meet best-in-class standards," said J.D. O'Hara, CEO of Internova Travel Group, one of the largest travel services companies in the world. "The services provided by Sharecare will be an important way to dynamically amplify the existing health safety protocols in place at hotels, as well as give travelers a recognizable certification that assures them that a hotel or resort is health security verified."

 

"The pandemic has made it clear that in order for the hospitality industry to scale for our new normal, hotels and resorts must, first and foremost, assure employees and guests of their safety," said Filip Boyen, CEO of Forbes Travel Guide, the global authority on genuine Five-Star service. "Sharecare Health Security verification with Forbes Travel Guide gives guests, travel planners, and hotel staff an added layer of confidence that the places away from home where they choose to work, play, and stay are committed to health security at a time when they absolutely need it."

 

Created in light of the disastrous effect COVID-19 has had on the cordiality business, Sharecare's wellbeing security arrangement empowers inns to enhance existing wellbeing conventions and conform to master approved prescribed procedures to limit the danger and effect of intense general wellbeing functions. This organization is one of a few activities Internova Travel Group has embraced to advance more secure travel. A month ago, O'Hara and Internova chiefs guided a computerized wellbeing pass called CommonPass pointed toward supplanting isolate with COVID-19 testing. The organization's Travel Leaders Group division dispatched a program called "Book with Confidence," which furnishes taking an interest travel guides with a library of wellbeing and security related assets to help travelers.

 

"Our goal is to ensure our travelers can book with confidence, fly with confidence and stay with confidence," said O'Hara. "The more consistent information our advisors can provide to travelers, the more prepared and comfortable they will be in restarting their travels."

 

The wellbeing security arrangement from Atlanta-based industry-pioneer Sharecare, is a supplement to its leader information driven, virtual wellbeing stage that incorporates a far reaching COVID-19 status arrangement, Well-Being@Work.

 

"We are committed to empowering the hospitality industry to address the evolving emotional, educational, clinical, and operational challenges introduced by the pandemic by creating a culture of accountability that fosters resilience through well-being and health security," said Hermann Elger, president of travel, hospitality, and entertainment at Sharecare. "By combining our keen understanding of population health and digital innovation with the power of Forbes Travel Guide's expertise in unparalleled service and standards, we can ensure that physical facilities apply the appropriate safety protocols while employees and guests within those spaces have the tools and resources to stay safe and build resilience."

 

Internova expects all inns it works with to be Sharecare Health Security VERIFIED® with Forbes Travel Guide before the finish of Q1 2022. Internova's organization with Sharecare and Forbes Travel Guide was encouraged by Axcess Worldwide.

 

About Internova Travel Group

Internova Travel Group is one of the largest travel services companies in the world with a collection of leading brands delivering high-touch, personal travel expertise to leisure and corporate clients. Internova manages leisure, business and franchise firms through a portfolio of distinctive divisions. Internova represents more than 65,000 travel advisors in over 6,000 company-owned and affiliated locations predominantly in the United States, Canada and the United Kingdom, with a presence in more than 80 countries.

 

About Forbes Travel Guide

Forbes Travel Guide is the only independent, global rating system for luxury hotels, restaurants and spas. Started as Mobil Travel Guide in 1958, the company created the first Five-Star rating system in the United States. Today, Forbes Travel Guide's incognito inspectors travel the world, evaluating properties based on up to 900 rigorous, objective standards. Forbes Travel Guide also supports the hospitality industry and other service-oriented businesses such as luxury residential, healthcare and private clubs with bespoke training solutions, evaluation services and the creation of custom service standards.

 

About Sharecare

Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform and programs are designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving awareness, engagement, and positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone.

Spotlight

Universal health coverage (UHC) promises a world in which all people have access to the health services, vaccinations and medicines they need, without risk of financial hardship. A world where the right to health is realized for the 400 million people who currently lack access to basic, primary health care. The global community has committed to working together to deliver UHC by 2030 under the Sustainable Development Goals (SDGs). The challenge now is to translate aspirations to UHC into achievements.


Other News
HEALTH TECHNOLOGY

The GIANT Health Event 2021. Early bird tickets on sale now

GIANT Health | October 13, 2021

Europe's greatest festival of Health Tech Innovation | 30th Nov - 1st Dec 2021 Join us at GIANT this year and immerse yourself in Europe's greatest festival of healthcare innovation. Find inspiration from global leading innovators, and discover the advances in technology that are revolutionizing healthcare provision. GIANT 2021 is set to be our biggest event yet so don't miss out. GIANT Health event is an invaluable, cost-effective global hybrid event. Combining both a real-world physical trade show and multiple conferences in central London, as well as a sophisticated and engaging virtual event based on GIANT Health’s proprietary Virtual Event Platform. Learn more about Digital Therapeutics. Would you like to network with 1000s and 1000s of Europe's leading healthcare and technology innovators, hospital leaders, health-sector investors, and entrepreneurs? Over 400 speakers will convene in 15+ conference at the massive GIANT Health Event, 30 November - 1 December, 2021. Come join us in person or remotely. Early Bird tickets are now available. CLAIM YOUR TICKET HERE A special promotional code which allows to save up to 25% on top is available for our subscribers: MEDIA25 See you there! Media contact: GIANT Health Events Ltd Olga Nosova +44 20 8144 9779 Olga@GIANT.health

Read More

HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signaled, Life is the leading healthcare end-to-end programmatic platform. Life's automated machine learning and AI allows marketers to quickly create highly-customized segments that classify populations in real-time, and deliver sequential messaging to drive customer actions in the moment and across the health journey. This next generation of the Life platform includes: • Advanced media planning innovations: Life offers an AI-powered forecasting tool used to run simulations to generate predictive performance metrics and intelligent audience insights. This makes it easier for marketers to preview budgets and ideate and adjust tactics to obtain their desired campaign outcomes, all before a single dollar is spent. Each forecast is powered by detailed supply and channel insights, like expected delivery, and campaign performance can be viewed by a variety of dimensions, including creative types, domains/apps, condition categories, healthcare professional specialties, geographies, among others. • Better campaign management with advanced dashboard: An automated and real-time view of line item performance and pacing gives traders a deeper, more granular look into their campaigns, making it easier for them to optimize their spend based on flight delivery and anticipate new incremental opportunities. The dashboard not only surfaces key numbers, but it also includes dynamic performance charts to uncover real-time campaign insights. • Turnkey PMP (private marketplaces) deal builder: Enhanced with turnkey end-to-end functionality, self-serve traders can now enable the deals that they negotiated directly with publishers and/or SSPs through Life's UI, decreasing the time it takes to launch PMPs. "Life was built for the healthcare marketer to simplify and optimize marketing campaigns," said Andrew Stark, CRO of PulsePoint. "Our newest capabilities increase efficiencies through advanced forecasting and real-time performance optimization, enabling more control and enhanced campaign management." Life by PulsePoint provides access to over 110 billion daily impressions across more than 2 million health pages, reaching 1.8M+ opted-in, verified healthcare professionals and over 90% of the online U.S. population. This release is just another step in PulsePoint's journey to deliver personalized messaging at each stage of the health journey using predictive insights built on real-time data. The company was recently acquired by Internet Brands, a KKR portfolio company and owner of WebMD Health Corp. PulsePoint's teams will continue to operate as their own division from their existing hubs in New York, San Francisco, and London. About PulsePoint PulsePoint is a leading technology company that uses real-world data in real-time to optimize campaign performance and revolutionize health decision-making. Leveraging proprietary datasets and methodology, PulsePoint targets healthcare professionals and patients with an unprecedented level of accuracy—delivering unparalleled results to the clients we serve.

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think there will always be a place for face-to-face events; and we are contracted with ExCeL for a live ‘in person’ event four years in advance to 2025. However, as a result of international travel restrictions, health professionals in global markets are looking for on-line engagement”. Future Health offers buyers and sellers the ability to operate on line, and to research and access the products and services that their hospitals and citizens desperately need. Dawn concluded, “In the immediate post COVID era, health buyers want to be able to operate from the comfort of their desk or smart device, and they now can, from literally anywhere in the world”. AboutFuture Health Future Health is an independent exhibition and conference organiser, based in London in the UK. For further information regarding exhibiting, visiting and sponsorship opportunities at Future Health Innovations or UK Health Week Please call +44 (0) 208 012 8511 Email: hello@futurehealthinnovations.com or to sign up to the Future Health platform, register at www.futurehealthinnovations.com

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for FlexiTrack 035™, Peripheral Balloon Catheter for Endovascular Applications Bonn, Germany – L2Mtech GmbH has announced the award of its first CE Mark approval on Six (6) products: LimusTrack™ : Sirolimus Coated Cobalt Chromium Stent with biodegradable polymer for the treatment of coronary artery disease, de novo lesions, restenosis lesions. LomiFlow™ : Paclitaxel Coated balloon catheter for the treatment of coronary artery disease, small vessels, dilatation of de novo lesions, in-stent restenosis (ISR) cases. PearlFlow™ : Paclitaxel Coated balloon catheter for the treatment of peripheral arterial disease, PTA, dilatation of stenotic segments or lesions in peripheral arteries. PearlFlow NS™ : Self-Expanding Nitinol Stent System for the treatment of peripheral arterial disease, de novo lesions, lesions in femoropopliteal arteries. FlexiTrack 018™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in femoral, popliteal, tibial arteries. FlexiTrack 035™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in the SFA, femoral arteries. L2Mtech GmbH Founder and CEO Lalit Mamtani said ‘‘We are very excited to have been awarded our first CE Mark on six products, CE Mark approval represents a key milestone for L2Mtech GmbH and is a testament to the efficacy and safety of our innovative technology products for Cardiovascular and Endovascular applications.“ We now prepare to commercially launch the products in all markets where the CE Mark is recognized. With introduction of our innovative technology products in markets, we will be able to expand treatment options for the benefit of many millions of patients with coronary and peripheral artery disease around the world. About L2Mtech Founded in 2017, L2Mtech GmbH is a privately-owned multinational medical device company headquartered at Bonn, Germany. L2Mtech specializes in design, development, manufacture and commercialization of medical devices that are used by healthcare establishments globally. L2MTech will provide interventional physicians with innovative vascular devices including Drug Eluting Balloon manufactured in Europe.Our Core mission is to build a product portfolio focused on minimally invasive treatment for patients with cardiovascular,endovascular and vascular artery disease. For further information, please visit : L2MTech.de Media Contact: L2Mtech GmbH admin@L2Mtech.de +49 228 94730761

Read More

Spotlight

Universal health coverage (UHC) promises a world in which all people have access to the health services, vaccinations and medicines they need, without risk of financial hardship. A world where the right to health is realized for the 400 million people who currently lack access to basic, primary health care. The global community has committed to working together to deliver UHC by 2030 under the Sustainable Development Goals (SDGs). The challenge now is to translate aspirations to UHC into achievements.

Resources

Events